| 期 |
栏目 |
标题 |
文件 |
| 编号 14 (2012) |
Articles |
Arterial'naya gipertenziya i kognitivnye narusheniya: vozmozhnosti korrektsii |
|
| 编号 14 (2012) |
Articles |
Variabel'nost' arterial'nogo davleniya -novaya mishen' dlya profilaktiki insul'ta |
|
| 编号 13 (2013) |
Articles |
Vliyanie amlodipina na kognitivnye funktsii u pozhilykh bol'nykh arterial'noy gipertoniey |
|
| 编号 6 (2014) |
Articles |
Dislipidemiya u patsienta s arterial'noy gipertenziey: kombinirovannaya terapiya gipolipidemicheskimi i antigipertenzivnymi lekarstvennymi sredstvami |
|
| 编号 18 (2014) |
Articles |
Vozmozhnosti korrektsii dislipidemii u patsientov s arterial'noy gipertenziey |
|
| 编号 9 (2017) |
Articles |
ALGORITHM OF THE SELECTION OF ANTIHYPERTENSIVE THERAPY AGAINST THE INVOLVEMENT OF HEART AS A TARGET ORGAN IN ARTERIAL HYPERTENSION |
|
| 编号 15 (2017) |
Articles |
Possibilities of amlodipine/lisinopril fixed-dose combination in real clinical practice |
|
| 编号 15 (2017) |
Articles |
Cerebroprotective effects of fixed-dose combination of perindopril arginine/ indapamide |
|
| 卷 26, 编号 9 (2019) |
Articles |
Drug-induced pirouette-type tachycardia |
|
| 卷 26, 编号 9 (2019) |
Articles |
Drug-induced nightmares |
|
| 卷 27, 编号 13 (2020) |
Articles |
The role of the disturbances in the intestinal barrier structure in relation to cardiovascular diseases pathogenesis and rebamipid potential in their correction |
|
| 卷 27, 编号 13 (2020) |
Articles |
Drug-induced liver injury with cholestasis. Part 1: focus on drugs for the treatment of cardiovascular diseases and hypoglycemic drugs |
|
| 卷 27, 编号 14 (2020) |
Articles |
Drug-induced liver injury with cholestasis. Part 2: focus on antidiabetic drugs |
|
| 卷 28, 编号 2 (2021) |
Articles |
Drug-induced autoimmune hepatitis |
|
| 卷 28, 编号 3 (2021) |
Articles |
Drug-induced atrial fibrillation/flutter associated with drugs affecting the central nervous system |
|
| 卷 28, 编号 10 (2021) |
Articles |
Potential clinically significant drug interactions of drugs with green tea |
|
| 卷 28, 编号 11 (2021) |
Articles |
Risk factors of drug-induced diseases. Part 1. Classification, non-modified risk factors |
|
| 卷 28, 编号 13 (2021) |
Articles |
Drug-alcohol interactions: focus on central-acting drugs and analgesics |
|
| 卷 28, 编号 13 (2021) |
Articles |
Interactions between alcohol and drugs: focus on drugs used to treat diseases of the cardiovascular system, gastrointestinal tract, antimicrobial drugs |
|
| 卷 28, 编号 13 (2021) |
Articles |
Possibilities of using trimetazidine in the treatment of patients with ischemic heart disease and chronic heart failure |
|
| 卷 29, 编号 6 (2022) |
Articles |
Drug-induced kidney stone disease |
|
| 卷 29, 编号 6 (2022) |
Articles |
Drugs, the use of which is associated with the development of drug-induced kidney stone disease. Part 1 |
|
